Cure My Disease

Don't miss your cure!

 Log in / Sign up

Eye scans could spot Diabetes-Related vision damage years early

NCT ID NCT07705321

Ongoing Knowledge-focused Sponsor: University of Athens Source: ClinicalTrials.gov ↗

First seen Jul 15, 2026 · Last updated Jul 16, 2026 · Updated 1 time

Summary

This study uses a non-invasive eye scan called OCTA to examine tiny blood vessels in the retina of adults with type 1 diabetes. The goal is to detect early signs of diabetic retinopathy, a leading cause of vision loss, before symptoms appear. Researchers will measure vessel density and other microvascular changes to better understand how diabetes affects the eyes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Optical coherence tomography angiography (OCTA) imaging
What this could lead to
If successful, this could enable earlier detection of diabetic retinopathy, potentially preventing vision loss through timely intervention.
What could go wrong
This is an observational study, not a treatment trial, so it won't directly improve outcomes. The findings may not translate into routine clinical practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES TYPE 1 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Diabetes Complications diabetic retinopathy type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES TYPE 1 DIABETIC COMPLICATIONS DIABETIC RETINOPATHY MICROVASCULAR CIRCULATION RETINAL MICROVASCULAR DISEASE

Contacts and locations

Locations

  • 2nd Department of Ophthalmology, Attikon University Hospital, National and Kapodistrian University of Athens

    Athens, 12462, Greece

More trials for these conditions

Other studies related to the condition(s) this trial covers.